Product Information
INPEFA 200 MG TABLET is a brand product labeled by Lexicon Pharmaceuticals, Inc., priced at $20.4998 per EA under NDC 70183022130. Its NADAC has been published 108 times since Jun 5, 2024.
Strength
200 mg/1
Manufacturer
Lexicon Pharmaceuticals, Inc.NDC
70183022130
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SOTAGLIFLOZINApproval Type
New Drug (NDA)
FDA Application
NDA216203On Market Since
5/26/2023
Pharmacological Classes
Price Statistics
The NADAC for INPEFA 200 MG TABLET has been published 108 times since Jun 5, 2024, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.4998 per EA |
|---|---|
| All-time high | $20.4998 (Jun 24, 2026) |
| All-time low | $19.1726 (Jun 5, 2024) |
| 52-week high | $20.4998 |
| 52-week low | $19.7149 |
| Median price | $19.7358 |
| Average price | $19.8499 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 108 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INPEFA 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INPEFA 200 MG TABLET, manufactured by Lexicon Pharmaceuticals, Inc., is $20.4998 per EA (NDC 70183022130), effective Jun 24, 2026.
How has the price of INPEFA 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for INPEFA 200 MG TABLET has risen 6.9%. It has been tracked across 108 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for INPEFA 200 MG TABLET?
Since Jun 5, 2024, the NADAC for INPEFA 200 MG TABLET has ranged from a low of $19.1726 (Jun 5, 2024) to a high of $20.4998 (Jun 24, 2026), with a median of $19.7358 per EA.
Are there cheaper alternatives to INPEFA 200 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, INPEFA 200 MG TABLET, is $19.7358 per EA — about 4% below INPEFA 200 MG TABLET.
Who manufactures INPEFA 200 MG TABLET?
INPEFA 200 MG TABLET (NDC 70183022130) is labeled by Lexicon Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification